Derniers ajouts - Macular Diseases - Acquired
|
Elmiron (pentasosan polysulfate) Macular Toxicityvu 114 fois77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15 Mars 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvu 95 fois77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15 Mars 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvu 96 fois77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15 Mars 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvu 45 fois77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15 Mars 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvu 46 fois77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15 Mars 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvu 50 fois77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15 Mars 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvu 58 fois77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15 Mars 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvu 54 fois77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15 Mars 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvu 45 fois77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15 Mars 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvu 48 fois77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15 Mars 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvu 49 fois77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15 Mars 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvu 51 fois77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15 Mars 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvu 53 fois77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15 Mars 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvu 53 fois77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15 Mars 2026
|
|
MacTel with foveal atrophy in both eyesvu 44 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
MacTel with foveal atrophy in both eyesvu 42 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
MacTel with foveal atrophy in both eyesvu 36 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
MacTel with foveal atrophy in both eyesvu 42 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
MacTel with foveal atrophy in both eyesvu 41 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
MacTel with foveal atrophy in both eyesvu 43 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
MacTel with foveal atrophy in both eyesvu 43 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
MacTel with foveal atrophy in both eyesvu 43 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
MacTel with foveal atrophy in both eyesvu 44 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
MacTel with foveal atrophy in both eyesvu 44 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
MacTel with foveal atrophy in both eyesvu 46 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
MacTel with foveal atrophy in both eyesvu 44 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
MacTel with foveal atrophy in both eyesvu 52 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
MacTel with foveal atrophy in both eyesvu 40 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
MacTel with foveal atrophy in both eyesvu 50 fois62 year old female with 20/50 OD, 20/40 OS.18 Février 2026
|
|
Latanoprost induced CMEvu 56 fois89 year old man with CME from latanoprost that cleared within one month of stopping the medication23 Novembre 2025
|
|
Latanoprost induced CMEvu 70 fois89 year old man with CME from latanoprost that cleared within one month of stopping the medication23 Novembre 2025
|
|
Latanoprost induced CMEvu 63 fois89 year old man with CME from latanoprost that cleared within one month of stopping the medication23 Novembre 2025
|
|
Latanoprost induced CMEvu 58 fois89 year old man with CME from latanoprost that cleared within one month of stopping the medication23 Novembre 2025
|
|
Latanoprost induced CMEvu 66 fois89 year old man with CME from latanoprost that cleared within one month of stopping the medication23 Novembre 2025
|
|
Latanoprost induced CMEvu 65 fois89 year old man with CME from latanoprost that cleared within one month of stopping the medication23 Novembre 2025
|
|
Latanoprost induced CMEvu 61 fois89 year old man with CME from latanoprost that cleared within one month of stopping the medication23 Novembre 2025
|
|
Latanoprost induced CMEvu 80 fois89 year old man with CME from latanoprost that cleared within one month of stopping the medication23 Novembre 2025
|
|
Latanoprost induced CMEvu 52 fois89 year old man with CME from latanoprost that cleared within one month of stopping the medication23 Novembre 2025
|
|
Latanoprost induced CMEvu 56 fois89 year old man with CME from latanoprost that cleared within one month of stopping the medication23 Novembre 2025
|
|
Latanoprost induced CMEvu 65 fois89 year old man with CME from latanoprost that cleared within one month of stopping the medication23 Novembre 2025
|
|
Latanoprost induced CMEvu 70 fois89 year old man with CME from latanoprost that cleared within one month of stopping the medication23 Novembre 2025
|
|
Latanoprost induced CMEvu 68 fois89 year old man with CME from latanoprost that cleared within one month of stopping the medication23 Novembre 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 83 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 79 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 75 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 74 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 69 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 75 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 73 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 60 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 69 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 65 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 75 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 64 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 90 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 66 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 72 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 56 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvu 76 fois74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517 Août 2025
|
|
Hydroxychloroquine Toxicityvu 102 fois60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22 Décembre 2024
|
|
Hydroxychloroquine Toxicityvu 126 fois60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22 Décembre 2024
|
|
Hydroxychloroquine Toxicityvu 125 fois60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22 Décembre 2024
|
|
Hydroxychloroquine Toxicityvu 124 fois60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22 Décembre 2024
|
|
Hydroxychloroquine Toxicityvu 115 fois60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22 Décembre 2024
|
|
Hydroxychloroquine Toxicityvu 107 fois60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22 Décembre 2024
|
|
Hydroxychloroquine Toxicityvu 101 fois60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22 Décembre 2024
|
|
Hydroxychloroquine Toxicityvu 133 fois60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22 Décembre 2024
|
|
Hydroxychloroquine Toxicityvu 144 fois60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22 Décembre 2024
|
|
Hydroxychloroquine Toxicityvu 108 fois60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22 Décembre 2024
|
|
Pseudophakic CME chronicvu 94 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 96 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 113 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 116 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 109 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 106 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 109 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 113 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 99 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 99 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 115 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 104 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 97 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 99 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 120 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 96 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 97 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 102 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 121 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 133 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 111 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Pseudophakic CME chronicvu 103 fois74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06 Novembre 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevu 118 fois60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OS17 Septembre 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevu 114 fois60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OS17 Septembre 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevu 117 fois60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OS17 Septembre 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevu 113 fois60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OS17 Septembre 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevu 96 fois60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OS17 Septembre 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevu 96 fois60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OS17 Septembre 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevu 90 fois60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OS17 Septembre 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevu 111 fois60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OS17 Septembre 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevu 94 fois60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OS17 Septembre 2024
|
|
| 2319 photos sur 24 page(s) |
1 |
 |
|
|
|
|
|
|
|
|
|
